CiteFacts · FDA Drug Shortages · FDA source
FDA shortage status: Desmopressin Acetate Spray
FDA source answer
FDA currently lists this ingredient in shortage.
FDA source statuses: Current. First FDA posting: 2021-03-12. Latest FDA row update: 2026-09-16.
FDA lists 4 package records, with companies: Apotex Corp., Ferring. Package NDCs: 0053-6871-00, 55566-2500-0, 60505-0815-0, 69918-501-05.
FDA shortage reason: Requirements related to complying with good manufacturing practices
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Package NDC | Presentation | FDA availability field | FDA update |
|---|---|---|---|---|
| Apotex Corp. | 60505-0815-0 | Desmopressin Acetate (needs No Refrigeration), Spray, 10 ug (NDC 60505-0815-0) | Available | 2026-09-16 |
| Ferring | 55566-2500-0 | Ddavp, Spray, .1 ug/1 mL (NDC 55566-2500-0) | Unavailable | 2026-05-01 |
| Ferring | 69918-501-05 | Desmopressin Acetate, Spray, 10 ug/.1 mL (NDC 69918-501-05) | Unavailable | 2026-05-01 |
| Ferring | 0053-6871-00 | Stimate, Spray, 1.5 mg/1 mL (NDC 0053-6871-00) | Unavailable | 2026-05-01 |
Source facts
Grouped generic ingredient: Desmopressin Acetate Spray · 4 package records
Therapeutic categories: Hematology
Dosage forms: Spray
Routes: Not stated
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-10-06T18:55:41+00:00. Derived grouping is documented in this record's derivations.